Advanced search
Publication Cover
Therapeutic Delivery Volume 11, 2020 - Issue 7
Submit an article Journal homepage
3,864
Views
0
CrossRef citations to date
0
Altmetric
Commentary

The Potential Role of Nanomedicine on COVID-19 Therapeutics

Rubiana Mara Mainardes1 Pharmaceutical Nanotechnology Laboratory, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia838 - CEPGuarapuava, PR 85040-167, BrazilCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4442-2075
ORCID Icon &
Camila Diedrich1 Pharmaceutical Nanotechnology Laboratory, Universidade Estadual do Centro-Oeste, Alameda Élio Antonio Dalla Vecchia838 - CEPGuarapuava, PR 85040-167, BrazilORCID Iconhttps://orcid.org/0000-0002-3549-2952
ORCID Icon
Pages 411-414 | Received 03 Jun 2020, Accepted 15 Jun 2020, Published online: 29 Jun 2020

References

  • Walls AC , ParkY-J , TortoriciMA , WallA , McGuireAT , VeeslerD. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell180, 1–12 (2020).
  • Khan M , KazmiS , BashirA , SiddiqueN. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J. Adv. Res.24, 91–98 (2020).
  • Wu D , WuT , LiuQ , YangZ. The SARS-CoV-2 outbreak: what we know. Int. J. Infect. Dis.94, 44–48 (2020).
  • Li H , LiuS , YuX , TangS , TangC. Coronavirus disease 2019 (COVID-19): current status and future perspective. Int. J. Antimicrob. Agents55, 105951 (2020).
  • Rothan HA , ByrareddySN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J. Autoimmun.109, 102433 (2020).
  • Lai CC , ShihTP , KoWC , TangHJ , HsuehPR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents55(3), 105924 (2020).
  • Wang L-S , WangY-R , YeD-W , LiuQ-Q. A review of the 2019 novel coronavirus (COVID-19) based on current evidence. Int. J. Antimicrob. Agents55(6), 105948 (2020).
  • Petrosillo N , ViceconteG , ErgonulO , IppolitoG , PetersenE. COVID-19, SARS and MERS: are +they closely related?Clin. Microbiol. Infect.26, 729–734 (2020).
  • Rodriguez-Morales AJ , Cardona-OspinaJA , Gutiérrez-OcampoEet al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med. Infect. Dis.34, 101623 doi:10.1016/j.tmaid.2020.101623 (2020) ( Epub ahead of print).
  • Yang Y , PengF , WangRet al. The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J. Autoimmun.109, 102434 (2020).
  • Negahdaripour M . The battle against COVID-19: where do we stand now?Iran J. Med. Sci.45(2), 81–82 (2020).
  • Pooladanda V , ThatikondaS , GoduguC. The current understanding and potential therapeutic options to combat COVID-19. Life Sci.254, 117765 (2020).
  • Kupferschmidt K , CohenJ. Race to find COVID-19 treatments accelerates. Science367(6485), 1412–1413 (2020).
  • Hu TY , FriemanM , WolfranJ. Insights from nanomedicine into chloroquine efficacy against COVID-19. Nat. Nanotechnol.15, 247–249 (2020).
  • Flühmann B , NtaiI , BorchardG , SimoensS , MühlebachS. Nanomedicines: the magic bullets reaching their target?Eur. J. Pharm. Sci.128, 73–80 (2018).
  • Patra JK , DasG , FracetoLFet al. Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnology16, 1–33 (2018).
  • Kerry RG , MalikS , ReddaYT , SahooS , PatraJK , MajhiS. Nano-based approach to combat emerging viral (NIPAH virus) infection. Nanomedicine18, 196–220 (2019).
  • Singh L , KrugerHG , MaguireGEM , GovenderT , ParboosingR. The role of nanotechnology in the treatment of viral infections. Ther. Adv. Infect. Dis.4(4), 105–131 (2017).
  • Milovanovic M , ArsenijevicA , MilovanovicJ , KanjevacT , ArsenijevicN. Nanoparticles in antiviral therapy. In: Antimicrobial Nanoarchitectonics: From Synthesis to Applications (1st Edition). Elsevier Inc.383–410 (2017).
  • Uskokovic V . Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?. Nanomedicine (Lond). doi:10.2217/nnm-2020-0163 (2020) ( Epub ahead of print).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.